Identifying COPD in lung cancer screening patients
Temple Health Chest Initiative (THCI 2.0) - Lung Cancer Screening Project With COPD Detection
This study is trying to find out how many people aged 50 to 80 who are getting lung cancer screenings actually have undiagnosed COPD and how early diagnosis might help them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Temple University Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06933758 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the prevalence of chronic obstructive pulmonary disease (COPD) among patients aged 50 to 80 who are being screened for lung cancer using low-dose CT imaging. By utilizing spirometry, CT scans, and symptom assessments, the study seeks to identify undiagnosed COPD cases and understand the impact of early diagnosis on patient outcomes. The research will also explore imaging biomarkers related to COPD and their potential role in assessing disease progression over time.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 50 to 80 who are undergoing lung cancer screening with low-dose CT imaging.
Not a fit: Patients under 50 or over 80 years old, or those not screened for lung cancer, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and better management of COPD in high-risk patients, potentially improving their quality of life and health outcomes.
How similar studies have performed: Other studies have shown success in identifying COPD through lung cancer screening programs, indicating a promising approach for this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50 to 80 years old * Screened for early lung cancer using low dose CT imaging Exclusion Criteria: * Under 50; over 80 years old * No lung cancer screening
Where this trial is running
Philadelphia, Pennsylvania
- Temple University Of the Commonwealth System of Higher Education — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Gerard Criner, MD — Temple University
- Study coordinator: Lauren Miller, BS
- Email: lauren.e.miller@temple.edu
- Phone: 215-707-4821
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.